|
2022-09-06 |
2022-09-01 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
360
-0.4%
77,06
27 742
USD
|
360
-0.4%
|
77,06
|
27 742
USD
|
|
|
2022-09-06 |
2022-09-01 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
240
-0.3%
75,88
18 210
USD
|
240
-0.3%
|
75,88
|
18 210
USD
|
|
|
2022-09-06 |
2022-09-01 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
1 088
-1.2%
78,68
85 602
USD
|
1 088
-1.2%
|
78,68
|
85 602
USD
|
|
|
2022-09-06 |
2022-09-01 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
2 720
-2.9%
77,92
211 934
USD
|
2 720
-2.9%
|
77,92
|
211 934
USD
|
|
|
2022-09-06 |
2022-09-01 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
1 750
-1.8%
76,96
134 677
USD
|
1 750
-1.8%
|
76,96
|
134 677
USD
|
|
|
2022-09-06 |
2022-09-01 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
1 200
-1.3%
75,93
91 114
USD
|
1 200
-1.3%
|
75,93
|
91 114
USD
|
|
|
2022-09-06 |
2022-09-01 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
452
-0.5%
78,66
35 556
USD
|
452
-0.5%
|
78,66
|
35 556
USD
|
|
|
2022-09-06 |
2022-09-01 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
2 955
-3.0%
78,09
230 741
USD
|
2 955
-3.0%
|
78,09
|
230 741
USD
|
|
|
2022-09-06 |
2022-09-01 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
1 914
-1.9%
77,00
147 382
USD
|
1 914
-1.9%
|
77,00
|
147 382
USD
|
|
|
2022-09-06 |
2022-09-01 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
1 047
-1.0%
75,94
79 504
USD
|
1 047
-1.0%
|
75,94
|
79 504
USD
|
|
|
2022-08-04 |
2022-08-03 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
5 396
-15.8%
74,00
399 304
USD
|
5 396
-15.8%
|
74,00
|
399 304
USD
|
|
|
2022-08-04 |
2022-08-03 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
563
-1.6%
71,09
40 024
USD
|
563
-1.6%
|
71,09
|
40 024
USD
|
|
|
2022-08-03 |
2022-08-02 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
414
-0.4%
69,66
28 839
USD
|
414
-0.4%
|
69,66
|
28 839
USD
|
|
|
2022-08-03 |
2022-08-02 |
V
Vente
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
837
-0.2%
69,66
58 305
USD
|
837
-0.2%
|
69,66
|
58 305
USD
|
|
|
2022-08-03 |
2022-08-02 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
437
-1.2%
69,66
30 441
USD
|
437
-1.2%
|
69,66
|
30 441
USD
|
|
|
2022-06-16 |
2022-06-10 |
VP
Vente planifiée
|
HILLEMAN JERYL L
Administrateur non-exécutif
|
407
-13.8%
69,61
28 331
USD
|
407
-13.8%
|
69,61
|
28 331
USD
|
|
|
2022-05-12 |
2022-05-11 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
2 135
-5.8%
61,25
130 769
USD
|
2 135
-5.8%
|
61,25
|
130 769
USD
|
|
|
2022-05-12 |
2022-05-10 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
2 070
-5.3%
65,16
134 877
USD
|
2 070
-5.3%
|
65,16
|
134 877
USD
|
|
|
2022-03-11 |
2022-03-09 |
V
Vente
|
Shah Pritesh
Chief Commercial Officer
Dirigeant
|
3 669
-4.2%
71,19
261 196
USD
|
3 669
-4.2%
|
71,19
|
261 196
USD
|
|
|
2022-03-09 |
2022-03-08 |
V
Vente
|
Longsworth Todd Christopher
General Counsel
Dirigeant
|
2 339
-3.6%
70,10
163 964
USD
|
2 339
-3.6%
|
70,10
|
163 964
USD
|
|
|
2022-03-09 |
2022-03-08 |
V
Vente
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
2 385
-0.4%
70,10
167 189
USD
|
2 385
-0.4%
|
70,10
|
167 189
USD
|
|
|
2022-03-09 |
2022-03-08 |
V
Vente
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Dirigeant
|
2 923
-1.7%
70,10
204 902
USD
|
2 923
-1.7%
|
70,10
|
204 902
USD
|
|
|
2022-03-09 |
2022-03-08 |
V
Vente
|
Shah Pritesh
Chief Commercial Officer
Dirigeant
|
2 481
-2.9%
70,10
173 918
USD
|
2 481
-2.9%
|
70,10
|
173 918
USD
|
|
|
2022-03-09 |
2022-03-08 |
V
Vente
|
Cordova Ashley
Chief Financial Officer
Dirigeant
|
759
-1.2%
70,10
53 206
USD
|
759
-1.2%
|
70,10
|
53 206
USD
|
|
|
2022-03-09 |
2022-03-08 |
V
Vente
|
Burke William Patrick
Chief Human Resources Officer
Dirigeant
|
1 037
-1.8%
70,10
72 694
USD
|
1 037
-1.8%
|
70,10
|
72 694
USD
|
|
|
2022-03-09 |
2022-03-08 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
744
-0.7%
70,10
52 154
USD
|
744
-0.7%
|
70,10
|
52 154
USD
|
|
|
2022-03-09 |
2022-03-07 |
V
Vente
|
Shah Pritesh
Chief Commercial Officer
Dirigeant
|
5 294
-5.9%
69,55
368 198
USD
|
5 294
-5.9%
|
69,55
|
368 198
USD
|
|
|
2022-03-07 |
2022-03-04 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
1 510
-3.4%
70,41
106 315
USD
|
1 510
-3.4%
|
70,41
|
106 315
USD
|
|
|
2022-03-07 |
2022-03-04 |
V
Vente
|
Burke William Patrick
Chief Human Resources Officer
Dirigeant
|
1 026
-1.8%
70,41
72 238
USD
|
1 026
-1.8%
|
70,41
|
72 238
USD
|
|
|
2022-03-07 |
2022-03-04 |
V
Vente
|
Cordova Ashley
Chief Financial Officer
Dirigeant
|
556
-0.9%
70,41
39 146
USD
|
556
-0.9%
|
70,41
|
39 146
USD
|
|
|
2022-03-07 |
2022-03-04 |
V
Vente
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Dirigeant
|
2 569
-1.5%
70,41
180 876
USD
|
2 569
-1.5%
|
70,41
|
180 876
USD
|
|
|
2022-03-07 |
2022-03-04 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
555
-0.5%
70,41
39 076
USD
|
555
-0.5%
|
70,41
|
39 076
USD
|
|
|
2022-03-07 |
2022-03-04 |
V
Vente
|
Shah Pritesh
Chief Commercial Officer
Dirigeant
|
1 914
-2.1%
70,41
134 759
USD
|
1 914
-2.1%
|
70,41
|
134 759
USD
|
|
|
2022-03-07 |
2022-03-04 |
V
Vente
|
Shah Pritesh
Chief Commercial Officer
Dirigeant
|
2 632
-2.8%
73,34
193 031
USD
|
2 632
-2.8%
|
73,34
|
193 031
USD
|
|
|
2022-03-07 |
2022-03-04 |
V
Vente
|
Longsworth Todd Christopher
General Counsel
Dirigeant
|
1 973
-3.0%
70,41
138 913
USD
|
1 973
-3.0%
|
70,41
|
138 913
USD
|
|
|
2022-03-07 |
2022-03-03 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
803
-1.8%
74,50
59 822
USD
|
803
-1.8%
|
74,50
|
59 822
USD
|
|
|
2022-03-07 |
2022-03-03 |
V
Vente
|
Burke William Patrick
Chief Human Resources Officer
Dirigeant
|
341
-0.6%
74,50
25 404
USD
|
341
-0.6%
|
74,50
|
25 404
USD
|
|
|
2022-03-07 |
2022-03-03 |
V
Vente
|
Cordova Ashley
Chief Financial Officer
Dirigeant
|
1 149
-1.8%
74,50
85 598
USD
|
1 149
-1.8%
|
74,50
|
85 598
USD
|
|
|
2022-03-07 |
2022-03-03 |
V
Vente
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Dirigeant
|
1 301
-0.8%
74,50
96 922
USD
|
1 301
-0.8%
|
74,50
|
96 922
USD
|
|
|
2022-03-07 |
2022-03-03 |
V
Vente
|
Leonard Frank X
Chief Development Officer
Dirigeant
|
930
-0.9%
74,50
69 283
USD
|
930
-0.9%
|
74,50
|
69 283
USD
|
|
|
2022-03-07 |
2022-03-03 |
V
Vente
|
Shah Pritesh
Chief Commercial Officer
Dirigeant
|
997
-1.0%
74,50
74 275
USD
|
997
-1.0%
|
74,50
|
74 275
USD
|
|
|
2022-03-07 |
2022-03-03 |
V
Vente
|
Longsworth Todd Christopher
General Counsel
Dirigeant
|
1 094
-1.6%
74,50
81 501
USD
|
1 094
-1.6%
|
74,50
|
81 501
USD
|
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Burke William Patrick
Chief Human Resources Officer
Dirigeant
|
399
-0.8%
76,03
30 336
USD
|
399
-0.8%
|
76,03
|
30 336
USD
|
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Burke William Patrick
Chief Human Resources Officer
Dirigeant
|
919
-1.8%
76,09
69 924
USD
|
919
-1.8%
|
76,09
|
69 924
USD
|
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Burke William Patrick
Chief Human Resources Officer
Dirigeant
|
2 633
-6.0%
75,96
200 003
USD
|
2 633
-6.0%
|
75,96
|
200 003
USD
|
|
|
2021-11-29 |
2021-11-26 |
A
Achat
|
Danziger Asaf
Chief Executive Officer
Administrateur exécutif
|
104
+0.8%
96,50
10 036
USD
|
104
+0.8%
|
96,50
|
10 036
USD
|
|
|
2021-11-29 |
2021-11-26 |
A
Achat
|
Danziger Asaf
Chief Executive Officer
Administrateur exécutif
|
1 000
+8.2%
103,37
103 370
USD
|
1 000
+8.2%
|
103,37
|
103 370
USD
|
|
|
2021-11-29 |
2021-11-26 |
A
Achat
|
Danziger Asaf
Chief Executive Officer
Administrateur exécutif
|
3 870
+46.6%
102,36
396 133
USD
|
3 870
+46.6%
|
102,36
|
396 133
USD
|
|
|
2021-11-03 |
2021-11-02 |
V
Vente
|
Cordova Ashley
Chief Financial Officer
Dirigeant
|
209
-0.5%
107,28
22 421
USD
|
209
-0.5%
|
107,28
|
22 421
USD
|
|
|
2021-08-16 |
2021-08-12 |
V
Vente
|
Cordova Ashley
Chief Financial Officer
Dirigeant
|
2 606
-5.4%
140,90
367 185
USD
|
2 606
-5.4%
|
140,90
|
367 185
USD
|
|
|
2021-08-16 |
2021-08-12 |
V
Vente
|
Cordova Ashley
Chief Financial Officer
Dirigeant
|
7 298
-13.7%
140,90
1 028 288
USD
|
7 298
-13.7%
|
140,90
|
1 028 288
USD
|
|
|
2021-08-16 |
2021-08-12 |
V
Vente
|
Cordova Ashley
Chief Financial Officer
Dirigeant
|
2 767
-5.7%
140,90
389 870
USD
|
2 767
-5.7%
|
140,90
|
389 870
USD
|
|
|
2021-08-16 |
2021-08-12 |
V
Vente
|
Cordova Ashley
Chief Financial Officer
Dirigeant
|
8 026
-14.9%
140,90
1 130 879
USD
|
8 026
-14.9%
|
140,90
|
1 130 879
USD
|
|
|
2021-08-16 |
2021-08-12 |
V
Vente
|
Cordova Ashley
Chief Financial Officer
Dirigeant
|
5 927
-11.4%
141,06
836 063
USD
|
5 927
-11.4%
|
141,06
|
836 063
USD
|
|
|
2021-06-08 |
2021-06-07 |
VP
Vente planifiée
|
LEUNG GABRIEL
Administrateur non-exécutif
|
1 000
-1.4%
204,55
204 550
USD
|
1 000
-1.4%
|
204,55
|
204 550
USD
|
|
|
2021-05-28 |
2021-05-27 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
1 833
-5.9%
200,00
366 600
USD
|
1 833
-5.9%
|
200,00
|
366 600
USD
|
|
|
2021-05-14 |
2021-05-12 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
1 943
-6.3%
180,48
350 673
USD
|
1 943
-6.3%
|
180,48
|
350 673
USD
|
|
|
2021-05-06 |
2021-05-05 |
VP
Vente planifiée
|
LEUNG GABRIEL
Administrateur non-exécutif
|
1 000
-1.4%
199,67
199 670
USD
|
1 000
-1.4%
|
199,67
|
199 670
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
LEUNG GABRIEL
Administrateur non-exécutif
|
2 500
-3.4%
200,00
500 000
USD
|
2 500
-3.4%
|
200,00
|
500 000
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
LEUNG GABRIEL
Administrateur non-exécutif
|
3 500
-4.5%
198,01
693 035
USD
|
3 500
-4.5%
|
198,01
|
693 035
USD
|
|
|
2021-04-15 |
2021-04-13 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
3 474
-9.5%
200,00
694 800
USD
|
3 474
-9.5%
|
200,00
|
694 800
USD
|
|
|
2021-04-15 |
2021-04-13 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
651
-1.9%
200,00
130 200
USD
|
651
-1.9%
|
200,00
|
130 200
USD
|
|
|
2021-04-15 |
2021-04-13 |
V
Vente
|
Benaim Ely
Chief Medical Officer
Dirigeant
|
1 833
-5.2%
200,00
366 600
USD
|
1 833
-5.2%
|
200,00
|
366 600
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
600
-0.1%
216,69
130 016
USD
|
600
-0.1%
|
216,69
|
130 016
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
500
-0.1%
214,67
107 333
USD
|
500
-0.1%
|
214,67
|
107 333
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
1 500
-0.3%
213,35
320 021
USD
|
1 500
-0.3%
|
213,35
|
320 021
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
600
-0.1%
211,28
126 766
USD
|
600
-0.1%
|
211,28
|
126 766
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
521
-0.1%
210,18
109 504
USD
|
521
-0.1%
|
210,18
|
109 504
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
2 200
-0.4%
209,34
460 555
USD
|
2 200
-0.4%
|
209,34
|
460 555
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
4 500
-0.8%
207,80
935 118
USD
|
4 500
-0.8%
|
207,80
|
935 118
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
1 284
-0.2%
206,35
264 956
USD
|
1 284
-0.2%
|
206,35
|
264 956
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
1 600
-0.3%
205,43
328 690
USD
|
1 600
-0.3%
|
205,43
|
328 690
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
1 972
-0.3%
204,28
402 834
USD
|
1 972
-0.3%
|
204,28
|
402 834
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
2 555
-0.4%
203,25
519 311
USD
|
2 555
-0.4%
|
203,25
|
519 311
USD
|
|
|
2021-04-15 |
2021-04-13 |
VP
Vente planifiée
|
DOYLE WILLIAM F
Executive Chairman
Administrateur exécutif
|
4 388
-0.8%
202,16
887 069
USD
|
4 388
-0.8%
|
202,16
|
887 069
USD
|
|
